David Cladingboel
Fisons
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by David Cladingboel.
Bioorganic & Medicinal Chemistry Letters | 1994
Moya Caffrey; David Cladingboel; Martin Cooper; David Keith Donald; Mark Furber; David Norman Hardern; Richard P. Harrison; Michael J. Stocks; Simon J. Teague
Abstract A number of dual domain, macrocyclic FKBP12 ligands were synthesised in which the FK506 effector domain was fused to simplified FKBP12 bindings domains. The resulting macrocyclic compounds possessed moderate binding affinities for FKBP12 but showed no activity in an assay for FKBP12 dependent calcineurin inhibition.
Bioorganic & Medicinal Chemistry Letters | 1994
Timothy N. Birkenshaw; Moya Caffrey; David Cladingboel; Martin Cooper; David Keith Donald; Mark Furber; David Norman Hardern; Richard P. Harrison; David Peter Marriott; Matthew W.D. Perry; Michael J. Stocks; Simon J. Teague; W.John Withnall
Abstract A number of FKBP12 ligands were designed and synthesised and their affinity for FKBP12 assessed. In these ligands the pyranose ring of FK506 was replaced by other more synthetically accessible groups. The preparation of suitable intermediates for the synthesis of “dual domain” inhibitors (compounds 6a–c, 15 and 22) is also described.
Tetrahedron | 1994
Yusuf Özlü; David Cladingboel; Philip J. Parsons
Abstract A novel free radical cyclisation approach for the synthesis of lysergic acid analogues has been investigated. The homolytic cleavage of carbon-bromine bond, mediated by tri-n-butyltin hydride, led to the development of a method for the construction of 3,4-disubstituted dihydroindoles via single cyclisation; hexahydrobenz[cd]indoles via double tandem cyclisations and both octahydroindolo[6,5,4-cd]indoles and decahydroindolo[4,3-fg]quinolines via triple radical cyclisations. A successful tandem double 5-exo-trig,6-endo-trig cyclisation of aryl radical generated from N-3-[3-(N-acetyl-N-allylamino)-2-bromophenyl]-5-(carbomethoxy)-1,4,5,6-tetrahydro-N-methylpyridine afforded methyl 1-acetyl-2,3,9,10-tetrahydrolysergate.
Journal of The Chemical Society, Chemical Communications | 1990
David Cladingboel; Philip J. Parsons
The lysergic acid ring system, characteristic of the ergot alkaloids, is constructed from 2-bromoaniline derivatives by triple radical cyclisation, initiated with tri-n-butyltin hydride; formation of a 6- rather than a 5-membered D ring is controlled by a terminal phenylthio group.
Journal of Medicinal Chemistry | 2007
Mark Furber; Lilian Alcaraz; Janice Bent; Armin Beyerbach; Keith Bowers; Martin Braddock; Moya Caffrey; David Cladingboel; John Collington; David Keith Donald; Malbinder Fagura; Frank Ince; Elizabeth Kinchin; Celine Laurent; Mandy Lawson; Timothy Jon Luker; Michael Mortimore; Austen Pimm; Robert J. Riley; Nicola J. Roberts; Mark J. Robertson; Jill Theaker; Philip Thorne; Richard Weaver; Peter J. H. Webborn; Paul Willis
Archive | 2004
David Cladingboel; Rhonan Ford; Paul Willis
Archive | 2000
David Cheshire; David Cladingboel; Martin Cooper; David Norman Hardern; Simon Hirst; Carol Manners; Michael J. Stocks
Archive | 2000
Andrew Douglas Baxter; Thomas Mcinally; Michael Mortimore; David Cladingboel
Archive | 1998
Andrew Douglas Baxter; Stephen Brough; Thomas Mcinally; Michael Mortimore; David Cladingboel
Archive | 1998
David Cheshire; David Cladingboel; Martin Cooper; David Norman Hardern; Simon Hirst; Carol Manners; Michael J. Stocks